Form 4 for KRMD KORU Medical Systems, Inc.
Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-17 · accession 0001161697-25-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-21 | 2025-03-17+ | KRMD | Tharby Linda M | CEO, Dir | F - Tax | $2.84 | -38.7K | 1.08M | -3% | -$109.9K |
| D | 2025-03-21 | 2025-03-17 | KRMD | Tharby Linda M | CEO, Dir | M - OptEx | $0.00 | +16.0K | 1.09M | +1% | $0 |
| D | 2025-03-21 | 2025-03-17 | KRMD | Tharby Linda M | CEO, Dir | M - OptEx | — | -16.0K | 47.9K | -25% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-19 | F | D | 29,813 | $2.83 | 1,046,750 | D | — | — | (F4) Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. |
| 2 | Common | Common Stock | 2025-03-17 | M | A | 15,968 | $0.00 | 1,085,411 | D | — | — | (F1) Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. (F4) Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. |
| 3 | Common | Common Stock | 2025-03-17 | F | D | 8,848 | $2.89 | 1,076,563 | D | — | — | (F4) Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. |
| 4 | Derivative | Restricted Stock Unit | 2025-03-17 | M | D | 15,968 | — | 47,904 | D | — · — to — | 15,968 Common Stock | (F5) This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. |